Loader

Pathways

PathWhiz ID Pathway Meta Data

PW002462

Pw002462 View Pathway
metabolic

Porphyrin Metabolism

Saccharomyces cerevisiae
Porphyrins are organic compounds. Many porphyrins are involved in oxygen transportation. Porphyrin ring biosynthesis begins in the mitochondria and involves glycine and succinyl-CoA condensation by δ-aminolevulinic acid synthase (ALAS) to produce δ-aminolevulinic acid (ALA), also known as 5-aminolevulinic acid. ALA is then transported to the cytosol where it becomes dimerized by ALA dehydratase (also known as porphobilinogen synthase) to produce porphobilinogen. The pathway continues with the condensation of 4 molecules of porphobilinogen catalyzed by porphobilinogen deaminase (PBG deaminase, also called hydroxymethylbilane synthase or uroporphyrinogen I synthase) to produce hydroxymethylbilane. Hydroxymethylbilane may then be converted to uroporphyrinogen III, a heme intermediate, or it may be non-enzymatically cyclized to uroporphyrinogen I. In the cytosol, uroporphyrinogen I and III substituents become decarboxylated to become coproporphyrinogens. Coproporphyrinogen III is an important intermediate in the synthesis of heme. In the inner mitochondria, coproporphyrinogen III undergoes decarboxylation of 2 propionate residues producing protoporphyrinogen IX. Protoporphyrinogen IX oxidase converts protoporphyrinogen IX to protoporphyrin IX. The final reaction of heme synthesis is ferrochelatase catalyzing the insertion of iron into the ring, producing heme b. Heme is broken down when heme oxygenase opens the heme ring. This oxidation produces linear tetrapyrrole biliverdin, ferric iron (Fe3+), and carbon monoxide (CO). Biliverdin reductase then produces bilirubin.

PW127399

Pw127399 View Pathway
drug action

Posaconazole Action Pathway

Homo sapiens
Posaconazole is a triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. For prophylaxis of invasive Aspergillus and Candida infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severely immunocompromised as a result of procedures such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), or due to hematologic malignancies with prolonged neutropenia from chemotherapy. Posaconazole is an antifungal agent structurally related to itraconazole. It is a drug derived from itraconzaole through the replacement of the chlorine substituents with flourine in the phenyl ring, as well as hydroxylation of the triazolone side chain. These modifications enhance the potency and spectrum of activity of the drug. Posaconazole can be either fungicial or fungistatic in action. Posaconazole binds to the enzyme lanosterol 14-alpha demethylase which inhibits the synthesis of 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol . Lanosterol 14-alpha demethylase is the enzyme that catalyzes the synthesis of 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol from lanosterol. With this enzyme inhibited ergosterol synthesis cannot occur which causes a significant low concentration of ergosterol in the fungal cell. Ergosterol is essential in maintaining membrane integrity in fungi. Without ergosterol, the fungus cell cannot synthesize membranes thereby increasing fluidity and preventing growth of new cells. This leads to cell lysis which causes it to collapse and die.

PW145346

Pw145346 View Pathway
drug action

Posaconazole Drug Metabolism Action Pathway

Homo sapiens

PW176119

Pw176119 View Pathway
metabolic

Posaconazole Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Posaconazole are predicted with biotransformer.

PW132164

Pw132164 View Pathway
metabolic

Potassium acetate Drug Metabolism

Homo sapiens
Potassium acetate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Potassium acetate passes through the liver and is then excreted from the body mainly through the kidney.

PW146820

Pw146820 View Pathway
drug action

Potassium acetate Drug Metabolism Action Pathway

Homo sapiens

PW145967

Pw145967 View Pathway
drug action

Potassium alum Drug Metabolism Action Pathway

Homo sapiens

PW132297

Pw132297 View Pathway
metabolic

Potassium aspartate Drug Metabolism

Homo sapiens
Potassium aspartate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Potassium aspartate passes through the liver and is then excreted from the body mainly through the kidney.

PW146942

Pw146942 View Pathway
drug action

Potassium aspartate Drug Metabolism Action Pathway

Homo sapiens

PW132168

Pw132168 View Pathway
metabolic

Potassium bicarbonate Drug Metabolism

Homo sapiens
Potassium bicarbonate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Potassium bicarbonate passes through the liver and is then excreted from the body mainly through the kidney.